BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11345832)

  • 1. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.
    Maitra A; Murakata LA; Albores-Saavedra J
    Am J Clin Pathol; 2001 May; 115(5):689-94. PubMed ID: 11345832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
    Pitman MB; Triratanachat S; Young RH; Oliva E
    Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors.
    Kanitakis J; Chouvet B; Claudy A; Scoazec JY
    Am J Clin Pathol; 2004 Jul; 122(1):85-9. PubMed ID: 15272534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen.
    Fasano M; Theise ND; Nalesnik M; Goswami S; Garcia de Davila MT; Finegold MJ; Greco MA
    Mod Pathol; 1998 Oct; 11(10):934-8. PubMed ID: 9796718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.
    Lugli A; Tornillo L; Mirlacher M; Bundi M; Sauter G; Terracciano LM
    Am J Clin Pathol; 2004 Nov; 122(5):721-7. PubMed ID: 15491968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma.
    Mac MT; Chung F; Lin F; Hui P; Balzer BL; Wang HL
    Am J Clin Pathol; 2009 Jul; 132(1):80-5. PubMed ID: 19864237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
    Chu PG; Ishizawa S; Wu E; Weiss LM
    Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of carcinoembryonic antigen in early gastric adenocarcinomas versus benign gastric lesions defined by monoclonal antibodies reactive with restricted antigen epitopes.
    Ohuchi N; Wunderlich D; Fujita J; Colcher D; Muraro R; Nose M; Schlom J
    Cancer Res; 1987 Jul; 47(13):3565-71. PubMed ID: 3555774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
    Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
    Villari D; Caruso R; Grosso M; Vitarelli E; Righi M; Barresi G
    Pathology; 2002 Oct; 34(5):423-6. PubMed ID: 12408340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathological study of hepatoid gastric adenocarcinomas].
    Song H; Li S; Yang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):56-9. PubMed ID: 7544725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1.
    Sugiki T; Yamamoto M; Aruga A; Takasaki K; Nakano M
    J Surg Oncol; 2004 Nov; 88(2):104-7. PubMed ID: 15499598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoid carcinoma of the ovary: a report of three cases admixed with a common surface epithelial carcinoma.
    Tochigi N; Kishimoto T; Supriatna Y; Nagai Y; Nikaido T; Ishikura H
    Int J Gynecol Pathol; 2003 Jul; 22(3):266-71. PubMed ID: 12819394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
    Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
    Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody to a human pancreatic carcinoma cell line recognizes gastrointestinal neoplasms.
    Kahn HJ; Yeger H; Loftus R; Goldrosen MH
    Am J Pathol; 1989 Mar; 134(3):641-9. PubMed ID: 2466406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
    Hanif R; Mansoor S
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal cancer-associated antigen in immunoperoxidase assay.
    Atkinson BF; Ernst CS; Herlyn M; Steplewski Z; Sears HF; Koprowski H
    Cancer Res; 1982 Nov; 42(11):4820-3. PubMed ID: 6751528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.